NORBIT ASA
Trondheim, Norway, 4 February 2021: NORBIT, a global provider of tailored technology to carefully selected niches, will announce its results for the fourth quarter of 2020 on Wednesday 10 February 2021.
The results will be available from 07:00 am CET at the company's homepage, www.norbit.com and Oslo Stock Exchange's news site, www.newsweb.no.
CEO Per Jørgen Weisethaunet and CFO Per Kristian Reppe will present the results from 13:00 through a webinar hosted by Sparebank 1 Markets. To participate, please register for the webinar by using the following link: https://attendee.gotowebinar.com/register/2407378922757894160.
A recording of the webinar will be made available from the company’s website.
For more information, please contact:
Per Kristian Reppe, CFO, +47 900 33 203
About NORBIT ASA
NORBIT is a global provider of tailored technology to carefully selected niches. The company's business is structured to address its key markets; Oceans is offering tailored technology solutions to global maritime markets, Intelligent Traffic Systems (ITS) is offering connectivity solutions for vehicle identification and tracking, and Product Innovation and Realization (PIR) is offering R&D services and contract manufacturing to key customers.
NORBIT is headquartered in Trondheim, Norway, with manufacturing facilities in Selbu and Røros, Norway and 14 offices and subsidiaries around the world.
For more information: www.norbit.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Basilea Pharmaceutica AG, Allschwil16.9.2025 07:15:00 CEST | Press release
Basilea receives USD 25 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
dsm-firmenich16.9.2025 07:00:45 CEST | Press release
Weekly progress on share repurchase program to cover share plans and reduce capital
CGTN16.9.2025 04:50:29 CEST | Press release
CGTN: Film on Japan's infamous WWII germ warfare unit to debut on September 18
2025 CIFTIS16.9.2025 04:25:28 CEST | Press release
China-Australia ties have "exciting opportunities" especially in services trade: Australian accounting expert
Novo Nordisk A/S16.9.2025 00:03:20 CEST | Press release
People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom